|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Frederik L. Giesel , Rodney Hicks , Ken HerrmannPublisher: Elsevier - Health Sciences Division Imprint: Elsevier - Health Sciences Division Volume: 18 Weight: 0.540kg ISBN: 9780323938952ISBN 10: 0323938957 Pages: 240 Publication Date: 01 June 2023 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand We will order this item for you from a manufactured on demand supplier. Table of ContentsAdvanced Fibroblast Activation Protein-Ligand Developments: FAP Imaging Agents: A Review of the Structural Requirements Fibroblast Activation Protein Inhibitor PET in Pancreatic Cancer The Diagnostic Value of Fibroblast Activation Protein Imaging in Hepatocellular Carcinoma and Cholangiocellular Carcinoma Fibroblast Activation Protein Inhibitor PET Imaging in Head and Neck Cancer Fibroblast Activation Protein Inhibitor-PET Imaging in Colorectal Cancer Fibroblast Activation Protein Inhibitor PET/CT in Gastric Cancer Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer Fibroblast Activation Protein Inhibitor (FAPI)-PET Imaging in Sarcoma Fibroblast Activation Protein Inhibitor Theranostics: The Case for Use in Sarcoma Radiation Therapy Planning Using Fibroblast Activation Protein Inhibitor Imaging Fibrosis Cardiac Applications of Fibroblast Activation Protein Imaging Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Considerations Fibroblast Activation Protein Inhibitor Theranostics: Preclinical Combination Treatment Fibroblast Activation Protein Inhibitor Theranostics: Early Clinical Translation Current State of Clinical Trials and Regulatory Approvals with Fibroblast Activation Protein Targeting InterventionsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |